U.S. Congress legislation · 119th Congress
HB10336: Dietary Supplement Innovation Act
Status: In committee, September 10, 2026
To amend the Federal Food, Drug, and Cosmetic Act to encourage innovation and increase and protect consumer access with respect to dietary supplements by clarifying the regulatory framework governing drug preclusion, and for other purposes.
What the bill says
To amend the Federal Food, Drug, and Cosmetic Act to encourage innovation and increase and protect consumer access with respect to dietary supplements by clarifying the regulatory framework governing drug preclusion, and for other purposes.
From the introduced text, September 10, 2026:
A BILL To amend the Federal Food, Drug, and Cosmetic Act to encourage innovation and increase and protect consumer access with respect to dietary supplements by clarifying the regulatory framework governing drug preclusion, and for other purposes. SECTION 1. Short title This Act may be cited as the Dietary Supplement Innovation Act . SECTION 2. Clarification of drug preclusion with respect to food and dietary supplements (a) Prohibited act Section 301(ll) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 331(ll) ) is amended to read as follows: (ll) The introduction or delivery for introduction into interstate commerce of any food (including a dietary supplement) to which has been added a drug approved under section 505 of this Act, a biological product licensed under section 351 of the Public Health Service Act, or a drug or biological product for which Phase 2 or Phase 3 (as such terms are described in section 312.21(b) of title 21, Code of Federal Regulations (or successor regulations)) clinical investigations have been instituted and for which the existence of such investigations has been made public, unless-- (1) the drug or biological product was marketed in the United States before October 15, 1994, as or in-- (A) food; or (B) a product that, if the definition of the term dietary supplement under section 201(ff) …
Sponsors
- Diana Harshbarger (R, HD-001) · primary sponsor
Latest actions
- : Referred to the House Committee on Energy and Commerce.
- : Introduced in House
Subjects: Health
Common questions
- What is HB10336?
- HB10336 is a bill in Congress (119th Congress): Dietary Supplement Innovation Act.
- What does HB10336 do?
- In its own words: To amend the Federal Food, Drug, and Cosmetic Act to encourage innovation and increase and protect consumer access with respect to dietary supplements by clarifying the regulatory framework governing drug preclusion, and for other purposes.
- What is the status of HB10336?
- In committee as of September 10, 2026. Latest action: Referred to the House Committee on Energy and Commerce. (September 10, 2026).
- Who sponsored HB10336?
- Diana Harshbarger (R, HD-001).
- Where is the official record for HB10336?
- On the Congress website: https://www.congress.gov/bill/119th-congress/house-bill/10336
Source: official Congress record. Tracked by Delilah, AI for legislation across all 50 states and Congress.